Monday, May 18, 2026
33.1 C
New Delhi

1.1 crore craft workers earn below min wage

1.1 crore craft workers earn below min wage

NEW DELHI: Despite employing one in every four workers in manufacturing, the handicrafts and handloom (HH) sector is marred by low productivity, occupational hazards, lack of formalisation, market access including e-commerce and exports, the latest study by the Institute for Human Development (IHD) in collaboration with Crafts Council of India released on Monday showed.The gross value added (GVA) per worker in the sector was estimated at Rs 270 a day, lower than the minimum wage prescribed by govt, as the HH sector is estimated to employ nearly 1.1 crore people across 65 lakh establishments in the year 2024. “Since most of these establishments are run and operated by a single person, their value added can be taken as their earnings, which is a paltry amount,” said GC Manna, professor at IHD.The primary survey was conducted in five states of Assam, Rajasthan, Tamil Nadu, UP and Bengal based on HH units enumerated in the sixth economic census conducted by NSO in 2013. “The HH establishments of five states together contributed Rs 51,445 crore of annual GVA. In terms of annual GVA per worker, the average for five states was about Rs 84,000 (a year)… which falls well below the prescribed daily minimum wage,” the study said.It found that majority of establishments operated from within the household premises and merely 2.6% establishments across the country employed more than 5 workers, showing the “proprietary” nature of these units, meaning that a single person owns and operates them with more women being proprietors than men. In Rajasthan, the share of women proprietors stood at 94%.”A significant proportion of handloom establishments remain unregistered under any formal scheme or programme. Further, a very low proportion of HH establishments-maintained accounts. The overall proportion of formally trained artisans and weavers remain low,” the official study noted.The survey also found that half of the handloom units in Tamil Nadu (66%), UP (51%), Assam (50%) and West Bengal (48%) reported decline or stagnation in the scale of production in the past decade.In Rajasthan, the share stood at 30%. Competition from mass production and copying, lack of skilled workers and space also emerged as major problems being faced by these establishments.”Use of exhibitions and fairs has been found to be minimal, contrary to held belief. No use was reported of e-commerce or of contract with khadi authorities, export agencies or private companies,” the study said. Less than 1% units reported sale of their products through organised fairs and exhibitions in Tamil Nadu, Uttar Pradesh and West Bengal.

Go to Source

Hot this week

Trump Says ‘Very Good Chance’ Of Nuclear Deal, After Delaying Strikes On Iran

Donald Trump says there is a very good chance of a US Iran nuclear deal, reveals he delayed a planned military strike after Gulf leaders urged more time for negotiations. Read More

AIADMK veteran Semmalai quits, ex-DMK min PTR takes a break

CHENNAI: Signs of unrest within Dravidian majors after the recent Tamil Nadu assembly poll debacle intensified Monday, even as DMK president MK Stalin and AIADMK chief Edappadi K Palaniswami (EPS) assured cadres the two parties woul Read More

India now Naxal-free: HM

Home minister Amit Shah on Monday said the Union govt would do whatever it takes for the region to recoup the loss of over five decades worth of development in three to five years. Read More

Anti-Naxal security camps turn ‘seva deras’ in Bastar

JAGDALPUR: With Left-wing extremism (LWE) crushed, the camps set up by the security forces in the remote Bastar region to run anti-Naxal operations are being repurposed to serve the local population with doorstep delivery of a range o Read More

On Prabhakaran death anniv, Vijay backs SL Tamils’ rights

CHENNAI: Tamil Nadu chief minister C Joseph Vijay on Monday expressed solidarity with the global Tamil diaspora on the occasion of Mullivaikkal Remembrance Day. Read More

Topics

Trump Says ‘Very Good Chance’ Of Nuclear Deal, After Delaying Strikes On Iran

Donald Trump says there is a very good chance of a US Iran nuclear deal, reveals he delayed a planned military strike after Gulf leaders urged more time for negotiations. Read More

AIADMK veteran Semmalai quits, ex-DMK min PTR takes a break

CHENNAI: Signs of unrest within Dravidian majors after the recent Tamil Nadu assembly poll debacle intensified Monday, even as DMK president MK Stalin and AIADMK chief Edappadi K Palaniswami (EPS) assured cadres the two parties woul Read More

India now Naxal-free: HM

Home minister Amit Shah on Monday said the Union govt would do whatever it takes for the region to recoup the loss of over five decades worth of development in three to five years. Read More

Anti-Naxal security camps turn ‘seva deras’ in Bastar

JAGDALPUR: With Left-wing extremism (LWE) crushed, the camps set up by the security forces in the remote Bastar region to run anti-Naxal operations are being repurposed to serve the local population with doorstep delivery of a range o Read More

On Prabhakaran death anniv, Vijay backs SL Tamils’ rights

CHENNAI: Tamil Nadu chief minister C Joseph Vijay on Monday expressed solidarity with the global Tamil diaspora on the occasion of Mullivaikkal Remembrance Day. Read More

Ex-min faces FIR over Messi’s Kolkata event

Based on a complaint by Lionel Messi’s India tour organiser, Satadru Dutta, an FIR was filed on Monday against Bengal’s former sports minister Aroop Biswas, ex-DGP Rajeev Kumar, New Alipore councillor Juin Biswas, and IAS officer Sant Read More

Govinda’s security gets into altercation with fan; actor apologises

Govinda just proved to fans why he is the ultimate “Hero No. 1”.The actor has gone viral on social media after a video of him stepping in to save the day has gone viral online. Read More

US pharma co denied patent on hepatitis C combo therapy

. NEW DELHI: The Indian Patent Office has refused to grant a patent to US pharmaceutical firm AbbVie on its Hepatitis C combination therapy glecaprevir/pibrentasvir, marketed globally as Mavyret. Read More

Related Articles